Xintela AB (publ) (XINT.ST)

SEK 0.32

(-0.63%)

Eps Summary of Xintela AB (publ)

  • Xintela AB (publ)'s latest annual eps in 2023 was -0.13 SEK , up 64.86% from previous year.
  • Xintela AB (publ)'s latest quarterly eps in 2024 Q2 was -0.02 SEK , down -3.09% from previous quarter.
  • Xintela AB (publ) reported an annual eps of -0.37 SEK in 2022, up 11.9% from previous year.
  • Xintela AB (publ) reported an annual eps of -0.42 SEK in 2021, up 34.38% from previous year.
  • Xintela AB (publ) reported a quarterly eps of -0.02 SEK for 2024 Q2, down -3.09% from previous quarter.
  • Xintela AB (publ) reported a quarterly eps of -0.05 SEK for 2023 Q1, up 41.42% from previous quarter.

Annual Eps Chart of Xintela AB (publ) (2023 - 2013)

Historical Annual Eps of Xintela AB (publ) (2023 - 2013)

Year Eps Eps Growth
2023 -0.13 SEK 64.86%
2022 -0.37 SEK 11.9%
2021 -0.42 SEK 34.38%
2020 -0.64 SEK -4.92%
2019 -0.61 SEK -32.61%
2018 -0.46 SEK -2.22%
2017 -0.45 SEK -4.65%
2016 -0.43 SEK -10.26%
2015 -0.39 SEK -319.35%
2014 -0.09 SEK -20.31%
2013 -0.08 SEK 0.0%

Peer Eps Comparison of Xintela AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK 76.364%
Ziccum AB (publ) -1.54 SEK 91.558%
Modus Therapeutics Holding AB (publ) -1.01 SEK 87.129%
BioArctic AB (publ) 2.60 SEK 105.0%
Sprint Bioscience AB (publ) -0.01 SEK -1963.492%
Mendus AB (publ) -4.40 SEK 97.045%
Genovis AB (publ.) 0.94 SEK 113.83%
Intervacc AB (publ) -1.69 SEK 92.308%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK 40.909%
Active Biotech AB (publ) -0.17 SEK 23.529%
Magle Chemoswed Holding AB (publ) 1.13 SEK 111.504%
Bio-Works Technologies AB (publ) -1.57 SEK 91.72%
Aptahem AB (publ) -0.05 SEK -169.151%
Vicore Pharma Holding AB (publ) -3.22 SEK 95.963%
Kancera AB (publ) -0.80 SEK 83.75%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 98.693%
Fluicell AB (publ) -0.24 SEK 45.833%
Saniona AB (publ) -1.29 SEK 89.922%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK 31.579%
Biovica International AB (publ) -2.14 SEK 93.925%
Spago Nanomedical AB (publ) -0.43 SEK 69.767%
AcouSort AB (publ) -1.29 SEK 89.922%
Abliva AB (publ) -0.09 SEK -43.805%
Egetis Therapeutics AB (publ) -1.27 SEK 89.764%
Karolinska Development AB (publ) 0.02 SEK 750.0%
OncoZenge AB (publ) -1.36 SEK 90.441%
Amniotics AB (publ) -0.01 SEK -1081.818%
2cureX AB (publ) -1.85 SEK 92.973%
CombiGene AB (publ) -1.80 SEK 92.778%
Asarina Pharma AB (publ) -0.57 SEK 77.193%
Calliditas Therapeutics AB (publ) -8.69 SEK 98.504%
Camurus AB (publ) 7.78 SEK 101.671%
Corline Biomedical AB -0.08 SEK -54.394%
IRLAB Therapeutics AB (publ) -3.43 SEK 96.21%
Isofol Medical AB (publ) -0.23 SEK 43.478%
I-Tech AB 1.70 SEK 107.647%
Hansa Biopharma AB (publ) -15.83 SEK 99.179%
Cyxone AB (publ) -0.22 SEK 40.909%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 93.434%
Biosergen AB -0.60 SEK 78.333%
Cantargia AB (publ) -1.65 SEK 92.121%
NextCell Pharma AB -1.03 SEK 87.379%
Xspray Pharma AB (publ) -6.76 SEK 98.077%
Elicera Therapeutics AB (publ) -0.83 SEK 84.337%
Nanologica AB (publ) -2.05 SEK 93.659%
SynAct Pharma AB -6.64 SEK 98.042%
Annexin Pharmaceuticals AB (publ) -0.26 SEK 50.0%
Stayble Therapeutics AB (publ) -0.92 SEK 85.87%
LIDDS AB (publ) -0.63 SEK 79.365%
Lipum AB (publ) -4.45 SEK 97.079%
BioInvent International AB (publ) -5.02 SEK 97.41%
Alzinova AB (publ) -0.41 SEK 68.293%
Oncopeptides AB (publ) -1.96 SEK 93.367%
Pila Pharma AB (publ) -0.47 SEK 72.34%
Guard Therapeutics International AB (publ) -11.26 SEK 98.845%
Scandinavian ChemoTech AB (publ) -1.13 SEK 88.496%
Simris Alg AB (publ) -0.16 SEK 18.75%
Diamyd Medical AB (publ) -1.60 SEK 91.875%
Xbrane Biopharma AB (publ) -1.27 SEK 89.764%
Ascelia Pharma AB (publ) -3.24 SEK 95.988%
Diagonal Bio AB (publ) -0.32 SEK 59.375%